Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of SnF2 Toothpaste and CPC Mouthwash in Gingivitis and Plaque
NCT06660069Completed
- Sponsor
- Haleon
- Start
- Nov 2024
- Primary completion
- Mar 2025
- Modality
- DNA Intercalators/Alkylators, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, single-blind trial of stannous fluoride and cetylpyridinium chloride in gingivitis and dental plaque (3 arms), sponsored by Haleon. Primary endpoint: Overall Number of Bleeding Sites at 12 weeks. Started Nov 2024; status: completed.
02
Drugs
stannous fluoridecetylpyridinium chloride
03
Conditions
gingivitisdental plaque
Beyond the preview
Go deeper on NCT06660069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06660069.